Archive - July 2018
FDA Approves Nivestym (filgrastim-aafi), a Biosimilar to Neupogen
FDA Approves Tibsovo (ivosidenib) for Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation
Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
PureTech lifted by news of Roche deal
UK drug advisors recommend rescheduling of medical cannabis
Allergan, Molecular Partners’ AMD drug non-inferior to Lucentis
NICE backs radionuclide therapy for some neuroendocrine tumours
Aurora partners with PIPHealth and taps into patient panels